ArticleLeukemia2015

Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.

M Tokumasu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.